使用OMNI手术系统对原发性开角型青光眼行独立小梁管成形术与小梁切开术:美国眼科学会IRIS登记处36个月分析
基于美国眼科学会IRIS登记处的回顾性临床队列研究,纳入230只眼(196例患者)接受OMNI手术系统独立小梁管成形术与小梁切开术的原发性开角型青光眼或高眼压症患眼,随访至少6个月至36个月。结果显示平均眼压从基线22.1 mmHg降至随访期间15.1-16.7 mmHg,平均降眼压药物从基线2.1种降至1.1-1.8种,术后18个月内药物使用显著减少。作者认为该手术是寻求降眼压、减药或两者兼有的原发性开角型青光眼患者的合理MIGS选择。
要点
- 独立OMNI手术在36个月内使平均眼压从基线22.1 mmHg降至15.1-16.7 mmHg,各时间点较基线均有统计学显著下降(p<0.0001)。
- 平均降眼压药物从基线2.1种降至1.1-1.8种,术后18个月内显著减少(p≤0.0011),24和36个月无显著差异。
- 基线眼压≤18 mmHg的眼在36个月内药物使用减少,基线眼压>18 mmHg的眼在36个月内眼压有统计学显著下降。
核心结论
- 独立小梁管成形术与小梁切开术在术后长达36个月内提供临床和统计学显著的眼压下降。
- 基线眼压较低的眼有长期降眼压药物减少,基线眼压较高的眼有统计学显著的长期眼压下降。
- 独立OMNI手术是寻求降眼压、减药或两者兼有的原发性开角型青光眼患者的合理MIGS选择。
研究设计与样本
- 回顾性临床队列研究,使用美国眼科学会IRIS登记处数据。
- 纳入2016年1月1日或之后有已知侧别的原发性开角型青光眼或高眼压症患眼,接受OMNI手术系统独立小梁管成形术与小梁切开术,术后随访至少6个月至36个月。
- 排除既往滤过手术、OMNI手术90天内小梁成形术或联合白内障手术的眼。
- 共分析196例患者的230只眼。
主要发现
- 大多数眼为中度(40.0%)或重度(41.3%)原发性开角型青光眼。
- 三分之二(230只眼中的153只)为人工晶状体眼。
- 不到一半的手术(44.4%)由青光眼专科医生完成。
- 平均基线眼压为22.1(6.4)mmHg,36个月随访期间范围为15.1至16.7 mmHg,各时间点较基线p<0.0001,眼水平平均降低5.6-7.1 mmHg。
- 平均基线降眼压药物为2.1(1.5)种,36个月内范围为1.1至1.8种药物类别,术后18个月内使用有统计学显著减少(p≤0.0011),第24和36个月无显著差异。
关键数值与推荐
- 基线眼压≤18 mmHg的眼在36个月内降眼压药物使用减少。
- 基线眼压>18 mmHg的眼在36个月内眼压有统计学显著下降。
临床怎么用
- 作者认为独立OMNI手术是寻求降眼压、减药或两者兼有的原发性开角型青光眼患者的合理MIGS选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize long-term real-world clinical outcomes of standalone canaloplasty and trabeculotomy using the OMNI Surgical System (Sight Sciences) in patients with primary open-angle glaucoma (POAG). DESIGN: Retrospective, clinical cohort study utilizing the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) data. SUBJECTS: Patients/eyes in the IRIS Registry with POAG or ocular hypertension with known laterality on or after January 1, 2016 and undergoing standalone canaloplasty and trabeculotomy using the OMNI Surgical System with at least 6 months and up to 36 months of postoperative follow-up were included. Eyes were excluded for prior filtration surgery, trabeculoplasty within 90 days of the OMNI procedure, or concomitant cataract surgery. METHODS/OUTCOME MEASURES: Outcome measures included intraocular pressure (IOP) and glaucoma medication changes postoperatively. RESULTS: 230 eyes in 196 patients were analyzed. Most eyes had moderate (40.0 %) or severe (41.3 %) POAG. Two-thirds (153 of 230) were pseudophakic. Fewer than half of procedures (44.4 %) were performed by glaucoma specialists. Mean baseline IOP was 22.1 (6.4) mmHg and over 36 months of follow-up ranged from 15.1 to 16.7 mmHg (p < 0.0001 at every time point compared to baseline), with average eye-level reductions of 5.6-7.1 mmHg. The mean number of glaucoma medications used at baseline was 2.1 (1.5) and over 36 months ranged from 1.1 to 1.8 medication classes, with statistically significant decreases in utilization through 18 months postoperatively (p ≤ 0.0011) and nonsignificant at months 24 and 36. Eyes with lower baseline IOP (≤18 mmHg) had reductions in medication use through 36 months, and eyes with higher baseline IOP (>18 mmHg) had statistically significant reductions in IOP through 36 months. CONCLUSIONS: Standalone canaloplasty and trabeculotomy provides clinically and statistically significant reductions in IOP through up to 36 months postoperatively. Eyes with lower baseline IOP had long-term glaucoma medication reductions and eyes with higher baseline IOP had statistically significant long-term IOP reductions. Standalone OMNI surgery is a reasonable MIGS option for patients with POAG seeking IOP reduction, medication reduction, or both.
引用
- Radcliffe NM, Harris J, Garcia K, et al. Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Eyes with Primary Open-Angle Glaucoma: A 36-Month Analysis from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight). Am J Ophthalmol. 2024. PMID: 39722265. doi:10.1016/j.ajo.2024.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。